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The aim of this study was to determine whether levels 
of biologically active calmodulin are elevated in both 
lesional and uninvolved epidermis in psoriasis. Epider-
mal shave biopsies were obtained from normal controls 
and from both psoriatic plaques and nonlesional pso-
riatic skin. Following determination of the protein con-
tent, the calmodulin activity of the homogenized samples 
was then measured using a calmodulin-sensitive phos-
phodiesterase enzyme bioassay. In normal skin, calmo-
dulin activity was 1.29 ± 0.35 IJ.g calmodulin mg- 1 epi-
dermal protein (mean ± SEM, n = 12 volunteers) com-
pared to 7.88 ± 1.59 IJ.g calmodulin mg- 1 epidermal 
protein for plaque (n = 16 patients) and 10.19 ± 2.35 
IJ.g calmodulin mg-• epidermal protein for the unin-
volved skin of 12 of these patients. The levels of biolog-
ically active calmodulin were therefore elevated in both 
plaque and uninvolved epidermis of patients with pso-
riasis compared to epidermis from normal volunteers. 
These results suggest that an abnormality in the regu-
lation of calmodulin activity may be involved in the 
pathogenesis of psoriasis. 
Calmodulin, the intracellular calcium receptor protein, is 
involved in the regulation of several processes which have been 
reported to be abnormally elevated in psoriasis, including epi-
dermal cellular proliferation [1,2], cyclic nucleotide metabolism 
[3], and phospholipase A2 activity [4] with the consequent 
release of arachidonic acid and production of the inf1ammatory 
eicosanoids. So far there has been only one report of measure-
ments of calmodulin in psoriasis; using radioimmunoassay 
(RIA) it was shown that calmodulin levels were grossly elevated 
in the involved epidermis in psoriasis [5]. Calmodulin levels 
measured by RIA have been found to be higher than the levels 
of biologically active calmodulin in several tissues [6] . The aim 
of this study, therefore, was to investigate whether levels of 
biologically active calmodulin are also elevated in psoriatic 
epidermis. 
MATERIALS AND METHODS 
Control samples were obtained from healthy volunteers and from 
the uninvolved margins of excision biopsies of noninflammatory benign 
skin lesions. Samples were obtained from patients with psoriasis after 
informed consent. Thirteen patients had stable chronic plaque pso-
riasis, and 3 had unstable erythrodermic psoriasis. Eleven of the 16 
patients had received prior treatment within a week of the biopsies, 
and topical fluorinated corticosteroids had been used by all of these 11 
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Abbreviat ions: 
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patients, in combination with coal tar ointments in 4 and dithranol 
ointments in 2 of them. 
Epidermal shave biopsies approximately 3 mm in diameter were cut 
freehand under local anesthesia from clinically uninvolved skin and 
from psoriatic plaques. The forearm was the selected site in all patients 
and volunteers. 
The specimens w~re homogenized in 40 mt.:t Tris-HCl, pH 7.0 at 
room temperature with_ 100 !LM CaCI,, contammg SO mg/liter phenyl 
methyl sulphonyl_ fluon~e and 50 1-'1/hter pepstatm A, using a glass 
Dounc~ homogemzer. Ahquots of homogenate were taken for protein 
determmatwn by the method of Bradford [7] . Homogenates were 
heated to go·c for 6 min and denatured protein removed by centrifu-
gation and supernatants stored at -2o·c until assay. 
Calmodulin activity was measured using a commercial calmodulin-
sensitive phosphodiesterase enzyme as previously described [8]. 
The dtfference between means was assessed for significance by 
Student's t-test. Values of p < 0.05 were taken as statistically signifi-
cant. 
RESULTS 
The values obtained for calmodulin activity in normal and 
psoriatic epidermis are shown in Fig 1. Twelve of the 16 patients 
had calmodulin levels greater than the upper limit of the normal 
range in involved skin; furthermore, 9 out of 12 patients had 
levels greater than the upper limit of normal in uninvolved 
skin. The mean value ± SEM for calmodulin activity was 1.29 
± 0.35 IJ.g mg- 1 epidermal protein for 12 controls, 7.88 ± 1.59 
IJ.g mg- 1 epidermal protein for the psoriatic plaques of 16 
patients, and 10 ± 2.35 IJ.g mg- 1 epidermal protein for the 
uninvolved epidermis of 12 of these patients. Both plaque (p < 
0.001) and uninvolved epidermis (p < 0.01) levels of calmodulin 
activity were significantly greate r than in normal epidermis. 
There was no significant difference between the levels meas-
ured in involved and noninvolved skin for the 12 patients where 
comparison was possible. 
DISCUSSION 
Our data confirm the original observation [5] that calmodulin 
levels are elevated in psoriasis, but differs on two accounts 
from this study. Firstly, the calmodulin activity was increased 
6-fold, as compared to the 30-fold increase in levels reported 
by RIA; secondly, calmodulin activity was elevated in both 
psoriatic plaques and uninvolved skin, whereas levels in unin-
volved skin measured by RIA in the former study, did not differ 
significantly from the normal controls. Since increased phos-
pholipase Az activity [4] and an increased flash labeling index 
have been reported in nonlesional psoriatic skin [9,10], these 
increases in calmodulin activity seem appropriate. Elevation of 
calmodulin levels in uninvolved epidermis rules out any effect;; 
of topical treatment in raising calmodulin activity and also 
suggests the possibility that an abnormality in the regulation 
of calmodulin activity may be involved in the pathogenesis of 
psoriasis. Further work is required to compare RIA and biolog- I 
ically assayed calmodulin levels for the same patients, and to 
examine levels throughout treatment of psoriasis, both topically 
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FIG 1. Calmodulin activity in normal epidermis and in lesional and 
nonlesional psoriatic epidermis. 
and by systemic antimetabolites. It is attractive to speculate 
whether calmodulin inhibitors, such as t he phenothiazines, 
would have an effect on psoriasis. 
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